By modulating the trapping capabilities of saruparib and veliparib, respectively potent and weak PARP1 trappers [8, 30], our results indicate that PARP1 trapping is a key component of PARPi effectiveness in BRCA1m cancer cells. Here, PARP1 is linked to cancer.